Register
Login:
Share:
Email Facebook Twitter


London South East Natural Resources Webcast


Immupharma Share Chat (IMM)



Share Price: 27.60Bid: 27.10Ask: 27.60Change: -1.00 (-3.50%)Faller - Immupharma
Spread: 0.50Spread as %: 1.85%Open: 28.00High: 28.50Low: 27.00Yesterday’s Close: 28.60


Share Discussion for Immupharma


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Elegance
Posts: 1,078
Off Topic
Opinion:No Opinion
Price:27.60
RE: Elegance
Today 17:14
Strongman, so if we are waiting for the results from the pivotal study set, am I right in thinking these companies must have had this information for at least 6 weeks already possibly more? I don't know what the normal length of time is to conclude the study of the above results, appreciate its variable and do not want you to open your self up to abuse on here if that is what will happen should you guesstimate on previous experience.
 
Strongman
Posts: 529
Off Topic
Opinion:No Opinion
Price:27.60
Elegance
Today 16:53
They are looking at the data from the pivotal study data set. The results of these will be what we are waiting for first.

The extension trial is a separate matter and will be reported once completed.

Next Steps

The Board believes that there is a significant opportunity for an efficacious and safe treatment for lupus patients given the treatment alternatives currently available, and that there is a desire from both physicians and patients for such a treatment, as evidenced by the investigator and patient-led extension study described above. The Company will undertake a review of the pivotal study's full dataset and will work with its regulatory advisers to determine the optimal next steps.

And

Separately, as previously announced, following requests from both Investigators and patients involved in the Phase III study, ImmuPharma has initiated an additional study permitting all patients who participated in the Phase III study, to receive Lupuzor£ (plus "Standard of Care") for six months in an open-label scheme. *******The results will be gathered as an "extension" open label study, INDEPENDENT of the pivotal Phase III trial.*********** The Company looks forward to providing further updates regarding this study in due course.
Elegance
Posts: 1,078
Off Topic
Opinion:No Opinion
Price:27.60
RE: Dialogue with the Company...
Today 16:43
Indeed no news could be good news, great to have you onboard finally, thumbs up :)
Elegance
Posts: 1,078
Off Topic
Opinion:No Opinion
Price:27.60
RE: Dialogue with the Company...
Today 16:41
Once they have full data? Presume they have full data? Am I right in thinking it’s “once we have evaluated the full data” or are they waiting for more data from the extended test? If someone could advise that would be appreciated. SM thanks for the info earlier on 200k sell.
Nolupus
Posts: 456
Off Topic
Opinion:No Opinion
Price:27.10
RE: Dialogue with the Company...
Today 16:34
Well,

No news is good news :-)
masterinvestors
Posts: 523
Off Topic
Opinion:No Opinion
Price:27.40
View Thread (2)
Dialogue with the Company...
Today 16:05
We must state that we have been having a dialogue with the Company and are pleased to confirm that;

"The context of the European article is accurate being that Prof. Muller invented Lupuzor£, there are no serious side effects to the patient whilst taking the drug, and ImmuPharma has confirmed many times that we are talking to potential partners"

Once we have full data from the study, and evaluated it further we will release to the market

Not more to say on this....

As I have said before, once we have full data from the study, we will release to the market
Strongman
Posts: 529
Off Topic
Opinion:No Opinion
Price:27.40
RE: Large order or Sell?
Today 15:31
By the looks of it, we had a sell order around 200k size that has already been fed in this morning in 50 - 25k lumps. There are hardly any sellers left and sell side looks exhausted to me.
Elegance
Posts: 1,078
Off Topic
Opinion:No Opinion
Price:27.40
Large order or Sell?
Today 15:20
Well my small order was filled ages ago but still the price drops.. SM can you see if we have yet another large order to fill?
Elegance
Posts: 1,078
Off Topic
Opinion:No Opinion
Price:27.10
RE: IMMUPHARMA
Today 15:18
a2b yes I think he did and is now trying to assess their age by analysing if they did French or Spanish at school tut tut.
a-2-b
Posts: 923
Off Topic
Opinion:No Opinion
Price:27.10
View Thread (2)
RE: IMMUPHARMA
Today 14:32
Did you just assume a posters gender




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.